ImmunoGrid

The project will focus on establishing an infrastructure for the simulation of the immune system that integrates processes at molecular, cellular, and organ levels. It will be designed for applications that support clinical outcomes such as design of vaccines and immunotherapies and optimization of immunization protocols.

The immune system is a complex and adaptive learning system which has evolved to defend the individual. It has multiple levels (molecular, cellular, organ and tissue, organism, and organism-toorganism) and is also combinatorial in nature with a large number of products.

Immune intervention, such as vaccination, is the most effective method for the control of disease and the greatest achievements include eradication of smallpox, near-elimination of polio, and savings of some 170 million person-years. Vaccination has been used in the control of over two dozen diseases by the 50 or so successful vaccines which have been developed to date.

Large-scale studies of the immune system, also known as immunomics, is the key factor driving the current wave in vaccine development. The main objectives of ImmunoGrid are to:

  • Create computational models for the real-size human immune system (the Virtual Human Immune System Simulator).
  • Standardize immune system concepts, bioinformatics tools and information resources to enhance the computational models for preclinical and clinical applications.
  • Validate these models with experimental data and disseminate the tools developed to users such as vaccine and immunotherapy researchers and developers.

For further information, please visit:

Project co-ordinator:
The Interuniversity Consortium of Northeastern Italy for Automated Computing (CINECA) (IT)

Partners:

  • National Council of Research - CNR (IT),
  • National Council of Scientific Research - CNRS (FR),
  • University of Queensland (AU),
  • Technical University of Denmark (DK),
  • Birkbeck College, Univ. of London (UK),
  • University of Bologna (IT),
  • University of Catania (IT)

Timetable: from 02/06 – to 01/09

Total cost: € 2.622.274

EC funding: € 1,951,042

Instrument: STREP

Project Identifier: IST-2004-028069

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...